Cart
sales@molnova.com
CEF14, EBV Rta Protein 28-37
CAS No. 216862-58-7
CEF14, EBV Rta Protein 28-37( —— )
Catalog No. M30206 CAS No. 216862-58-7
CEF14, EBV Rta Protein (28-37) is the HLA a24-restricted epitope from the epstein-barr virus Rta Protein (28-37).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameCEF14, EBV Rta Protein 28-37
-
NoteResearch use only, not for human use.
-
Brief DescriptionCEF14, EBV Rta Protein (28-37) is the HLA a24-restricted epitope from the epstein-barr virus Rta Protein (28-37).
-
DescriptionCEF14, EBV Rta Protein (28-37) is the HLA a24-restricted epitope from the epstein-barr virus Rta Protein (28-37).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number216862-58-7
-
Formula Weight1244.37
-
Molecular FormulaC55H81N13O18S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Asp}{Tyr}{Cys}{Asn}{Val}{Leu}{Asn}{Lys}{Glu}{Phe}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Fortunellin-6-beta-D...
Reference standards.
-
VUT-MK142
VUT-MK142 is a new cardiomyogenic small molecule promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes,which may be useful to differentiate stem cells into cardiomyocytes for cardiac repair.VUT-MK142 was identified as the most promising candidate with respect to cardiomyogenic activity.?
-
Isoxepac
Isoxepac is a non-steroidal anti-antiphlogistic agent and analgesic.
